Incidence of precancerous cervical lesions decreasing among young women
the ONA take:
According to a new study published in the journal Cancer, researchers have found that the incidence of high-grade cervical lesions in young women has significantly decreased, but the declines were likely due to reduced screening.
Cervical intraepithelial neoplasia grade 2, 3, and adenocarcinoma in situ (CIN2+) lesions can be monitored as early indicators of the effect of human papillomavirus (HPV) vaccines.
For the study, researchers identified over 9,000 cases of CIN2+ among patients aged 18 to 39 years in California, Connecticut, New York, and Oregon.
Researchers found that from 2008 to 2012, the rates of CIN2+ significantly decreased among women aged 18 to 20 years in all four states and among 21- to 29-year-old women in Connecticut and New York.
Researchers found that screening rates also declined during that time period, suggesting that the decline in these cervical lesions is most likely due to fewer screenings, but could potentially be an effect of vaccination as well.
Incidence of high-grade cervical lesions in young women has significantly decreased, but the declines were likely due to reduced screening.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Recurrence Score Appears To Be Driving Personalized Treatment for Breast Cancer
- Smoking-related Cancer Deaths Highest in Southern United States
- Study Suggests More Men With Prostate Cancer Would Choose Active Surveillance if it Were Offered
- The Bounty of Failure: A Well-Versed Nursing Experience
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|